GDS · NASDAQ · STOCK
GDS Holdings (GDS) Stock Analysis
$31.00
52W $26.97 – $48.61
50/100
$6.04B
11.0
0.42
Is GDS Bullish or Bearish?
Mixed.
Innellis AI committee rates GDS Holdings Limited (GDS) Watch with a composite score of 50/100
, based on 6 analysts with 50% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +9.93 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -10.07 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- P/E of 10.6 is inexpensive for the broad market — Value
- 3 consecutive earnings beats -- consistent execution — Growth
Bear Case
- Debt-to-equity of 1.72 adds balance-sheet risk to the value case — Value
- EPS declining -42.3% YoY despite any revenue growth — Growth
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- Price structure making lower highs and lower lows — Technical
- MACD histogram negative -- bearish momentum — Technical
- Daily trend (downtrend) conflicts with the weekly trend (uptrend) -- fighting the larger trend — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
50/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 94%
of 287 Technology peers
Value Analyst
neutral
57
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ P/E of 10.6 is inexpensive for the broad market
− Debt-to-equity of 1.72 adds balance-sheet risk to the value case
Growth Analyst
neutral
50
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ 3 consecutive earnings beats -- consistent execution
− EPS declining -42.3% YoY despite any revenue growth
Technical Analyst
bearish
39
/ 100 · High confidence
Price action is deteriorating -- trend and/or momentum are working against this name
− Price structure making lower highs and lower lows
Risk Analyst
bearish
32
/ 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 1.72) amplifies downside in a stress scenario
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 50.1 to 50.1.
- New bearish signals: 1 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- Risk Analyst: +1 bearish signal(s).
- Value Analyst: +1 bullish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
50.1
Neutral
MACD Histogram
-0.046
Bearish Momentum
Trend Direction
Downtrend
Weekly: Uptrend
Market Structure
Mixed
Support
$30.56
Resistance
$35.91
Bollinger %B
0.44
Inside Bands
Price vs Moving Averages
EMA 9
$30.79
Above
EMA 21
$31.21
Below
EMA 50
$31.92
Below
EMA 200
$34.74
Below
Fundamental Analysis
Valuation
100
Growth
64
Profitability
35
Financial Health
67
Cash Flow
15
Valuation
P/E Ratio
11.0×
P/B Ratio
1.24×
PEG Ratio
-0.45
Dividend Yield
0.00%
52W High
$48.61
52W Low
$26.97
Quality & Growth
ROE
353.6%
ROA
118.6%
Gross Margin
2434.3%
Operating Margin
1690.4%
Revenue Growth YoY
—
Debt / Equity
1.47
AI Fundamental Assessment
P/E ratio of 11.0 (inexpensive relative to a 15-40x range); Price-to-book of 1.2x; PEG ratio of -0.4 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 3.5%; Return on assets of 1.2%; Net margin of 30.5%; Gross margin of 24.3%; Current ratio of 1.78 (healthy short-term liquidity); Debt-to-equity of 1.46; Free cash flow per share is negative (-4.04); Most recent quarter beat estimates by 819.0%; 3 consecutive earnings beats; EPS growth decelerating (+79.6% -> -66.7% QoQ); Average YoY EPS growth of 833.3%; Analyst estimates falling over recent quarters
Get the Full GDS Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →